StockData
Entera Bio Ltd. logo

Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$3.00−0.02 (-0.66%)

Close on Nov 17, 2026Market cap $519.43MP/E –Yield –

Entera Bio gross margin

Gross margin is gross profit as a percentage of revenue.

Entera Bio's gross margin for the twelve months ending Dec 31, 2025 was 0.0%. For fiscal 2025 it was 0.0%, against 5.0% the year before. The highest annual figure on record is 34.7% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20250.0%−5.0
FY2024Dec 31, 20245.0%−19.7
FY2022Dec 31, 202224.6%−10.0
FY2021Dec 31, 202134.7%+16.9
FY2020Dec 31, 202017.8%+6.8
FY2019Dec 31, 201911.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 20250.0%−42.9
Q4 FY2024Dec 31, 20240.0%−25.0
Q3 FY2024Sep 30, 20240.0%−25.0
Q2 FY2024Jun 30, 202415.8%−4.8
Q4 FY2022Dec 31, 202242.9%+25.3
Q3 FY2022Sep 30, 202225.0%−28.6
Q2 FY2022Jun 30, 202225.0%+15.8
Q1 FY2022Mar 31, 202220.6%−32.9
Q4 FY2021Dec 31, 202117.6%−22.8
Q3 FY2021Sep 30, 202153.6%+37.4
Q2 FY2021Jun 30, 20219.2%–
Q1 FY2021Mar 31, 202153.5%–
Q2 FY2020Jun 30, 202040.4%–
Q2 FY2019Jun 30, 201916.2%–

More Entera Bio figures

See a number that looks wrong?